SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-134665
Filing Date
2017-04-24
Accepted
2017-04-24 16:30:58
Documents
2
Period of Report
2017-05-25
Effectiveness Date
2017-04-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d316674ddef14a.htm DEF 14A 293309
2 GRAPHIC g316674g99n61.jpg GRAPHIC 35088
  Complete submission text file 0001193125-17-134665.txt   343041
Mailing Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404
Business Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404 408-649-7370
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37852 | Film No.: 17778554
SIC: 2834 Pharmaceutical Preparations